Latest Videos

The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning. Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.

Much of what we know about the cannabis plant and its effects on the human body has only been formally discovered in the past 60 years. A good deal of these pioneering investigations have involved today's Teach Me in 10 guest: Roger Pertwee, an emeritus professor at the University of Aberdeen.

Sensitive, flexible CCD-based imagers designed to support FDA 21 CFR Part 11 EU GMP Annex 11 regulations

Mining the world’s most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that’s driving the ongoing global pandemic.

Explore the medical condition known as bipolar disorder, and learn about its symptoms, causes, and treatments.

Although cytochrome P450 (CYP)-mediated metabolism continues to be of major importance for a large proportion of small molecule new drug candidates, various methods in recent decades have accelerated the development of drug candidates with significant non CYP-mediated metabolism.

As scientists, we are the very experts in discovering answers, but by missing out on invaluable, diverse perspectives, we’re missing out on crucial thinking that has the potential to unlock a new era of scientific greatness.

Pint of Science is a non-profit organized entirely by a grass-roots community of thousands of scientists across the world. Join this Teach Me in 10 session to hear Praveen Paul, the co-founder of Pint of Science, discuss how the festival was born and where she plans on taking it next.

Learn how Chromeleon software makes it easier to comply with regulations and ensure data integrity in your laboratory.

The tagline for the Rechavi lab at Tel Aviv University, Israel, is "The Laboratory for Radical Science", and in this Teach Me in 10 installment, you will find out why.